Pelthos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTHS and other ETFs, options, and stocks.About PTHS
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform "Nitricil".
CEOScott M. Plesha
CEOScott M. Plesha
Employees4
Employees4
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2021
Founded2021
Employees4
Employees4
PTHS Key Statistics
Market cap84.79M
Market cap84.79M
Price-Earnings ratio-1.47
Price-Earnings ratio-1.47
Dividend yield—
Dividend yield—
Average volume34.09K
Average volume34.09K
High today—
High today—
Low today—
Low today—
Open price$26.53
Open price$26.53
Volume0.00
Volume0.00
52 Week high$54.29
52 Week high$54.29
52 Week low$5.62
52 Week low$5.62
Stock Snapshot
The current Pelthos Therapeutics(PTHS) stock price is $27.49, with a market capitalization of 84.79M. The stock trades at a price-to-earnings (P/E) ratio of -1.47.
On 2025-12-09, Pelthos Therapeutics(PTHS) stock opened at $26.53, reached a high of —, and a low of —.
The Pelthos Therapeutics(PTHS)'s current trading volume is 0, compared to an average daily volume of 34.09K.
In the last year, Pelthos Therapeutics(PTHS) shares hit a 52-week high of $54.29 and a 52-week low of $5.62.
In the last year, Pelthos Therapeutics(PTHS) shares hit a 52-week high of $54.29 and a 52-week low of $5.62.
People also own
Based on the portfolios of people who own PTHS. This list is generated using Robinhood data, and it’s not a recommendation.